Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
abiraterone (zytiga) (1 trial)
cisplatin (platinol) (1 trial)
enzalutamide (xtandi) (1 trial)
radium-223 (xofigo) (2 trials)
Neoplasm Metastasis (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (4 total)